To further explore whether the decreased expression of HIF1α/HIF2α under HBO treatment conditions promoted glioma cell proliferation and chemosensitivity, CCK-8 assays and flow cytometry were used to detect the effect of HIF1α/HIF2α on glioma cell growth. The gene discussed is EPAS1; the disease is central nervous system cancer.